Management of Cannabis Withdrawal
For cannabis withdrawal, no specific medication is recommended as first-line treatment; instead, symptom management with supportive care in a supportive environment is the recommended approach, with symptomatic medications used as needed for specific symptoms like agitation and sleep disturbance. 1, 2
Clinical Presentation of Cannabis Withdrawal
Cannabis withdrawal syndrome typically:
- Begins 24-72 hours after cessation of regular use
- Peaks within the first week
- Can last 1-2 weeks (longer in heavy users) 2, 3
Common symptoms include:
- Anxiety, irritability, anger or aggression
- Disturbed sleep/vivid dreaming
- Depressed mood
- Loss of appetite
- Less common: chills, headaches, physical tension, sweating, stomach pain 3
Risk factors for more severe withdrawal:
- Heavy cannabis use (>1.5 g/day of inhaled cannabis or >20 mg/day of THC oil)
- Higher pre-cessation frequency of use
- Female gender (women report stronger physical symptoms) 2, 4
Treatment Approach
Non-Pharmacological Interventions (First-Line)
Supportive environment 1
- Quiet setting with minimal stimulation
- Ensure adequate hydration
- Regular reassurance and monitoring
- Brief interventions (5-30 minutes) incorporating individualized feedback
- Short-duration psychosocial support using motivational principles
- Cognitive behavioral therapy and motivational enhancement therapy
Symptomatic Medication Management
For specific symptoms, the following may be used:
- Sleep disturbance: Low-dose sedating medications (consider mirtazapine) 4
- Headaches/pain: Acetaminophen or NSAIDs 2
- Anxiety/agitation: Short-term benzodiazepines (use with caution) 2, 4
- Nausea: Antiemetics as needed
Pharmacological Options for Moderate-to-Severe Withdrawal
While no medications are specifically approved for cannabis withdrawal, evidence suggests:
Synthetic cannabinoids may be considered for heavy users with moderate-to-severe withdrawal:
Other medications with limited evidence:
Special Considerations
When to Consider Inpatient Treatment
- Patients with significant comorbid mental health disorders
- Polysubstance use
- Risk of severe withdrawal complications
- Inadequate social support 3, 4
Monitoring for Complications
- Depression or psychosis can occur during withdrawal and require close monitoring
- Seek specialist advice if these complications develop 1
- Monitor for cannabinoid hyperemesis syndrome in chronic users 2
Follow-up Care
- Offer follow-up appointments to assess progress
- For ongoing cannabis use problems not responding to brief interventions, refer for specialist assessment 1
- Consider mutual help groups where available
Common Pitfalls to Avoid
Underestimating withdrawal severity: Cannabis withdrawal is clinically significant and can lead to relapse if not properly addressed 2, 7
Overlooking gender differences: Women may experience more severe physical symptoms 4
Missing comorbid conditions: Withdrawal may exacerbate underlying psychiatric conditions 2
Using certain medications: Venlafaxine may worsen cannabis withdrawal symptoms 4
Inadequate duration of treatment: Symptoms can persist for several weeks in heavy users 3